Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Bristol Myers Squibb Stock Rises
Bristol-Myers Squibb Likely To Revalue Higher Following New Drug Approval
Bristol-Myers Squibb's stock is set to rise with FDA approvals, acquisitions, and a strong oncology portfolio, despite potential risks. Read more on BMY here.
Bristol Myers Squibb Stock Rises After Schizophrenia Drug Gets FDA Approval
Key Takeaways Bristol Myers Squibb's drug to treat schizophrenia was approved for use by the Food and Drug Administration.The pharmaceutical firm called Cobenfy the first new treatment for the illness in decades.
Cobenfy Approval Brings 20% Upside To Bristol Myers Squibb Stock
This is a big approval for the company, given that Cobenfy doesn’t have the classic side effects seen in other antipsychotic drugs.
15h
on MSN
Bristol Myers Squibb stock rises following FDA approval of its schizophrenia drug
CNBC's Angelica Peebles joins 'Fast Money' to report on Bristol Myers Squibb's stock rise following FDA approval of Cobenfy ...
Business Wire
13h
U.S. Food and Drug Administration Approves Bristol Myers Squibb’s COBENFY™ (xanomeline and trospium chloride), a First-In-Class Muscarinic Agonist for the Treatment of ...
U.S. FDA Approves Bristol Myers Squibb’s COBENFY, a First-In-Class Muscarinic Agonist for the Treatment of Schizophrenia in Adults ...
1d
on MSN
FDA approves new type of antipsychotic drug, a potential ‘game changer’
The approval comes less than a year Bristol Myers Squibb paid $14 billion to acquire the developer of the drug, Karuna ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Trending now
Hezbollah leader killed
Helene: How to help
Human rabies death in MN
Houthis attack US warships
121st loss of the season
NC dam failure ‘imminent’
Congressional Gold Medal
Dow closes at record high
Haney sues Garcia
Van Gogh paintings attacked
High-end brothel plea
ICE: Convicts roaming free
'Harry Potter' star dies
NY ballot appeal rejected
Troops to leave some bases
Meta hit with privacy fine
Deposition in AI suit
Diocese reaches settlement
Bill to use birth control
KY sues Express Scripts
Fed inflation gauge cools
Promotes watch collection
US charges three Iranians
ISR targets Hezbollah HQ
Ending password-sharing
Fake Biden robocalls fine
Pleads not guilty
Producing doc on Diddy
Killer gets life sentence
Feedback